Haiti vs South Sudan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Haiti
39.0%
in 2025
South Sudan
27.0%
in 2025
Haiti rank
160th
South Sudan rank
163rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Haiti
- South Sudan
How they compare
Haiti currently reports 39.0% against 27.0% in South Sudan, a difference of 12.0%.
That makes Haiti's figure about 1.4 times South Sudan's.
The two have swapped places 1 time across 15 shared years of data; in 2011 it was South Sudan ahead.
Haiti ranks 160th and South Sudan ranks 163rd of 194 countries.
Haiti has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Haiti | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.3% | 0.0% | 4.3% | Haiti |
| 2020s | 46.2% | 4.5% | 41.7% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Haiti or South Sudan?
- Haiti, at 39.0% against 27.0% in South Sudan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Haiti and South Sudan?
- 12.0%, with Haiti ahead.
- How many years of comparable data are there for Haiti and South Sudan?
- 15 years are reported by both, from 2011 to 2025.
- How do Haiti and South Sudan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Haiti ranks 160th and South Sudan ranks 163rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.